Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2017, Article ID 9686353, 3 pages
https://doi.org/10.1155/2017/9686353
Case Report

Rhodotorula Endogenous Endophthalmitis: A Novel Harbinger of the Injection Drug Epidemic in the United States

1Geisel School of Medicine at Dartmouth, Hanover, NH, USA
2Section of Ophthalmology, Dartmouth-Hitchcock Keene, Keene, NH, USA
3Section of Infectious Disease, Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
4Section of Ophthalmology, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA

Correspondence should be addressed to Michael E. Zegans; gro.kcochctih@snagez.e.leahcim

Received 6 March 2017; Accepted 27 March 2017; Published 5 April 2017

Academic Editor: Raul Colodner

Copyright © 2017 Preston M. Luong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Endogenous endophthalmitis is a rare but feared infectious ocular complication of injection drug use (IDU). The recent opioid epidemic in the United States threatens to increase the incidence of this disease. We report the first case of endogenous endophthalmitis in the United States caused by the emerging fungal pathogen Rhodotorula in an injection drug user which led to no light perception vision (NLP). Worldwide experience with Rhodotorula endogenous endophthalmitis is limited, but existing cases suggest infection by this particular fungal genus has a grim prognosis.